<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" humanitarian="0" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>SE-0-SE-6-5108013507-ETH-12182</iati-identifier>
  <reporting-org ref="SE-0" secondary-reporter="0" type="10">
   <narrative xml:lang="EN">Sweden</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="SV">AHRI 2016-2021, Forskningst&#xF6;d</narrative>
   <narrative xml:lang="EN">AHRI 2016-2021, Research Support</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">AHRI works to meet the reseach and capacity building demands of Ethiopia in biomedical fields. The aim of the current application is  to work in areas of high quality research, capacity building towards  national competence, information dicemination, innovation for &quot;more   health for the money&quot; concept, and to strengthen AHRI as an institution in order to maintain already strong competencies.</narrative>
   <narrative xml:lang="SV">Insatsen syftar till att st&#xE4;rka AHRI som ett centrum f&#xF6;r forskning inom biomedicin, samt att st&#xF6;dja forskarutbildning av h&#xF6;g kvalit&#xE9; genom kunskaps&#xF6;verf&#xF6;ring i samarbete med svenska universitet. Insatsen har 5 m&#xE5;l: 1) Forskning av h&#xF6;g kvalit&#xE9;, 2) Kapacitetsuppbyggnad f&#xF6;r nationell kompetens f&#xF6;r evidensbaserat beslutsfattande inom h&#xE4;lsoomr&#xE5;det, 3) spridning av forskningsresultat f&#xF6;r anv&#xE4;ndning i policy och praktik, 4) innovationer f&#xF6;r &#xF6;kad effektivitet inom h&#xE4;lsoomr&#xE5;det samt 5) st&#xE4;rkande av AHRI som institution. AHRI &#xE4;r ansvarigt f&#xF6;r genomf&#xF6;randet av insatsen, med st&#xF6;d av svenska universitet f&#xF6;r doktorandutbildning samt med medel fr&#xE5;n andra internationella forskningsinstitutioner. Insatsens totala budget &#xE4;r SEK 49,996,906.</narrative>
  </description>
  <description type="2">
   <narrative xml:lang="EN">The overarching goal of this intervention is to &quot;contribute to Ethiopia&apos;s ability to provide best health services to its citizens at any given time&quot;. The intermediate goal is to &quot;make Ethiopia highly competent to organize relevant research for good health policies and practices.&quot; Outcomes are expected in five core intervention areas within the programme: a) high quality, quickly adaptive research; b) National competence capacity building; c) information dissemination, promoting research relevance and use; d) Innovation for more health for the money; and e) AHRI institution strengthening.</narrative>
  </description>
  <participating-org ref="51000" role="2">
   <narrative xml:lang="EN">AHRI/Armauer Hansen Research Institute</narrative>
  </participating-org>
  <participating-org ref="SE-0" role="1" type="10">
   <narrative xml:lang="EN">Sweden</narrative>
  </participating-org>
  <participating-org ref="SE-6" role="3" type="10">
   <narrative xml:lang="EN">Swedish International Development Cooperation Agency</narrative>
  </participating-org>
  <participating-org ref="51000" role="4" type="80">
   <narrative xml:lang="EN">Uppsala universitet</narrative>
  </participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2016-07-01" type="1"></activity-date>
  <activity-date iso-date="2016-07-01" type="2"></activity-date>
  <activity-date iso-date="2022-07-31" type="3"></activity-date>
  <contact-info>
   <organisation>
    <narrative xml:lang="EN">Swedish International Development Cooperation Agency</narrative>
   </organisation>
   <telephone>+46 8 698 50 00</telephone>
   <email>sida@sida.se</email>
   <website>www.sida.se</website>
   <mailing-address>
    <narrative xml:lang="EN">Valhallav&#xE4;gen 199, 105 25 Stockholm, Sweden</narrative>
   </mailing-address>
  </contact-info>
  <recipient-country code="ET" percentage="100">
   <narrative xml:lang="EN">Ethiopia</narrative>
  </recipient-country>
  <sector code="121" percentage="100" vocabulary="2">
   <narrative xml:lang="EN">Health, General</narrative>
  </sector>
  <sector code="12182" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Medical research</narrative>
  </sector>
  <tag code="3.8" vocabulary="3">
   <narrative xml:lang="EN">3.8 - Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all.</narrative>
   <narrative xml:lang="SV">3.8 - &#xC5;stadkomma allm&#xE4;n h&#xE4;lso- och sjukv&#xE5;rd f&#xF6;r alla, som &#xE4;ven skyddar mot ekonomisk risk, tillg&#xE5;ng till grundl&#xE4;ggande h&#xE4;lso- och sjukv&#xE5;rd av god kvalitet liksom tillg&#xE5;ng till s&#xE4;kra, effektiva och ekonomiskt &#xF6;verkomliga grundl&#xE4;ggande l&#xE4;kemedel och vaccin av god kvalitet.</narrative>
  </tag>
  <tag code="3.B" vocabulary="3">
   <narrative xml:lang="SV">3.b - St&#xF6;dja forskning om och utveckling av vaccin och l&#xE4;kemedel mot de smittsamma och icke-smittsamma sjukdomar som i f&#xF6;rsta hand drabbar utvecklingsl&#xE4;nder. S&#xF6;rja f&#xF6;r tillg&#xE5;ng till ekonomiskt &#xF6;verkomliga grundl&#xE4;ggande l&#xE4;kemedel och vaccin, i enlighet med Doha-deklarationen om TRIPS-avtalet och folkh&#xE4;lsa, i vilken det bekr&#xE4;ftas att utvecklingsl&#xE4;nderna har r&#xE4;tt att fullt ut utnyttja den flexibilitet som avtalet om handelsrelaterade aspekter av immaterialr&#xE4;tter erbjuder f&#xF6;r att skydda folkh&#xE4;lsan och, framf&#xF6;r</narrative>
   <narrative xml:lang="EN">3.b - Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public healt</narrative>
  </tag>
  <tag code="3.D" vocabulary="3">
   <narrative xml:lang="EN">3.d - Strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and global health risks.</narrative>
   <narrative xml:lang="SV">3.d - St&#xE4;rka alla l&#xE4;nders, i synnerhet utvecklingsl&#xE4;ndernas, kapacitet n&#xE4;r det g&#xE4;ller tidig varning, riskreducering och hantering av nationella och globala h&#xE4;lsorisker.</narrative>
  </tag>
  <policy-marker code="5" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Convention on Biological Diversity</narrative>
  </policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Convention to Combat Desertification</narrative>
  </policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Framework Convention on Climate Change - Adaptation</narrative>
  </policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Framework Convention on Climate Change - Mitigation</narrative>
  </policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid to Environment</narrative>
  </policy-marker>
  <policy-marker code="11" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Disability</narrative>
  </policy-marker>
  <policy-marker code="10" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Disaster Risk Reduction(DRR)</narrative>
  </policy-marker>
  <policy-marker code="1" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Gender Equality</narrative>
  </policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Participatory Development/Good Governance</narrative>
  </policy-marker>
  <policy-marker code="9" significance="1" vocabulary="1">
   <narrative xml:lang="EN">Reproductive, Maternal, Newborn and Child Health (RMNCH)</narrative>
  </policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Trade Development</narrative>
  </policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="E01" vocabulary="1"></default-aid-type>
  <default-tied-status code="4"></default-tied-status>
  <budget>
   <period-start iso-date="2018-01-01"></period-start>
   <period-end iso-date="2018-12-28"></period-end>
   <value currency="USD" value-date="2018-01-01">146368.4065175366</value>
  </budget>
  <budget>
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-12-28"></period-end>
   <value currency="USD" value-date="2019-01-01">186127.179855963</value>
  </budget>
  <budget>
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-12-28"></period-end>
   <value currency="USD" value-date="2020-01-01">71229.2474239117</value>
  </budget>
  <budget>
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-12-28"></period-end>
   <value currency="USD" value-date="2021-01-01">22385.7104548263</value>
  </budget>
  <planned-disbursement>
   <period-start iso-date="2018-01-01"></period-start>
   <period-end iso-date="2018-12-28"></period-end>
   <value currency="USD" value-date="2018-01-01">146368.4065175366</value>
  </planned-disbursement>
  <planned-disbursement>
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-12-28"></period-end>
   <value currency="USD" value-date="2019-01-01">186127.1798559629</value>
  </planned-disbursement>
  <planned-disbursement>
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-12-28"></period-end>
   <value currency="USD" value-date="2020-01-01">71229.2474239117</value>
  </planned-disbursement>
  <planned-disbursement>
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-12-28"></period-end>
   <value currency="USD" value-date="2021-01-01">22385.7104548263</value>
  </planned-disbursement>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2016-07-01"></transaction-date>
   <value currency="USD" value-date="2016-07-01">453456.436627</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2018-11-28"></transaction-date>
   <value currency="USD" value-date="2018-11-28">108625.6098683605</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2018-12-28"></transaction-date>
   <value currency="USD" value-date="2018-12-28">37742.7966491761</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-28"></transaction-date>
   <value currency="USD" value-date="2019-03-28">63452.4476781692</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-28"></transaction-date>
   <value currency="USD" value-date="2019-09-28">74027.8556245307</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-28"></transaction-date>
   <value currency="USD" value-date="2019-12-28">48646.876553263</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-28"></transaction-date>
   <value currency="USD" value-date="2020-07-28">49513.0134532069</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-28"></transaction-date>
   <value currency="USD" value-date="2020-12-28">21716.2339707048</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-28"></transaction-date>
   <value currency="USD" value-date="2021-12-28">22385.7104548263</value>
  </transaction>
  <document-link format="APPLICATION/PDF" url="https://documents.iati.openaid.se/document/ethiopia/51080135-agreement.pdf">
   <title>
    <narrative xml:lang="EN">Agreement</narrative>
   </title>
   <category code="A09"></category>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://documents.iati.openaid.se/document/ethiopia/51080135_1stagrementamendmentReNo-costextensionavavtalet5108013506.pdf">
   <title>
    <narrative xml:lang="EN">Agreement</narrative>
   </title>
   <category code="A09"></category>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://documents.iati.openaid.se/document/ethiopia/51080135_SignedAgreement.pdf">
   <title>
    <narrative xml:lang="EN">Agreement</narrative>
   </title>
   <category code="A09"></category>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://documents.iati.openaid.se/document/ethiopia/51080135_Tredjeavtalsandringavavtalet.pdf">
   <title>
    <narrative xml:lang="EN">Agreement</narrative>
   </title>
   <category code="A09"></category>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://documents.iati.openaid.se/document/ethiopia/51080135_2ndAgreementamendmentSidaISPsigned.pdf">
   <title>
    <narrative xml:lang="EN">Agreement</narrative>
   </title>
   <category code="A11"></category>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://documents.iati.openaid.se/document/ethiopia/51080135_DecisiononAmendmentofContributionB201842.pdf">
   <title>
    <narrative xml:lang="EN">Decision</narrative>
   </title>
   <category code="A11"></category>
  </document-link>
  <result aggregation-status="0" type="2">
   <title>
    <narrative xml:lang="EN">Results achieved</narrative>
    <narrative xml:lang="SV">Uppn&#xE5;dda resultat</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Formal results, as compared to the objectives and the results framework, are expected to be presented in the annual report and during the annual meeting.&#xA0;
It was however clear during the SAB-annual review that AHRI have made great efforts to adapt to its new role as a federal research institute. AHRI is growing quickly to adapt to the situation and AHRI are hosting a few projects that shows that they are on the way to become an important research hub. AHRI is the host of the Ethiopian Grand Challenge Africa, a innovation granting initiative, and also the H3A mentioned above.</narrative>
   </description>
   <indicator ascending="0" measure="5">
    <title>
     <narrative xml:lang="EN">Not applicable</narrative>
    </title>
    <description>
     <narrative xml:lang="EN">No indicator available - only a description of the activity results is published</narrative>
    </description>
   </indicator>
  </result>
  <crs-add>
   <other-flags code="1" significance="1"></other-flags>
  </crs-add>
  <sida:contribution contributionid="51080135" xmlns:sida="http://sida.se/ns/contribution#"></sida:contribution>
  <sida:strategies xmlns:sida="http://sida.se/ns/strategies#">
   <sida:strategy code="1140102" currency="SEK" strategy-amount="0" strategy-end-date="2022-12-31" strategy-start-date="2015-01-01">
    <sida:title>Research cooperation 2015-2022</sida:title>
    <sida:titleSV>Forskningssamarbete 2015-2022</sida:titleSV>
   </sida:strategy>
  </sida:strategies>
 </iati-activity>
</iati-activities>
